|
시장보고서
상품코드
2050498
전임상 CRO 시장 : 서비스별, 유형별, 동물 모델별, 모델 시스템별, 용도별, 최종사용자별, 지역별Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography |
||||||
전임상 CRO 시장은 2026년에 74억 달러로 추정되고 있으며, 2033년까지 134억 9,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 74억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.00% | 2033년 시장 규모 예측 : | 134억 9,000만 달러 |
세계의 비임상 CRO 시장은 최근 제약사 및 생명공학 기업의 비임상 연구 활동 아웃소싱 수요 증가에 힘입어 최근 괄목할 만한 성장세를 보이고 있습니다. 전임상 CRO(Contract Research Organizations)는 신약개발 과정에서 매우 중요한 역할을 담당하고 있으며, 독성시험, 약동학 및 약력학 시험, 동물모델 개발 등 다양한 서비스를 제공하고 있습니다. 이러한 조직은 의약품 개발의 전임상 단계를 효율화하여 제약사가 핵심 역량에 집중하고 새로운 치료법을 신속하게 시장에 출시할 수 있도록 돕고 있습니다. 전임상 CRO 시장은 경쟁이 치열하며, 전 세계에서 사업을 운영하는 주요 기업이 여러개 존재하며, 고객의 진화하는 요구에 부응하기 위해 전문적인 서비스와 첨단 기술을 제공하고 있습니다. 제약업계가 R&D 비용 상승과 규제 당국의 감시 강화라는 도전에 직면한 가운데, 향후 수년간 전임상 CRO 서비스에 대한 수요는 더욱 확대될 것으로 예상됩니다.
시장 역학:
세계의 비임상 CRO 시장은 제약사 및 생명공학 기업의 비임상 연구 활동 아웃소싱 증가, 전문 비임상 서비스에 대한 수요 증가, 의약품 개발 비용 및 기간 단축에 대한 요구 등 여러 요인에 의해 주도되고 있습니다. 비임상시험을 CRO에 위탁함으로써 기업은 막대한 설비투자 없이도 전문적 노하우와 첨단 기술, 그리고 최첨단 시설을 이용할 수 있습니다. 또한 의약품 개발의 복잡성 증가와 엄격한 규제 요건을 준수해야 한다는 점도 전임상 CRO 서비스에 대한 수요를 더욱 촉진하고 있습니다. 그러나 전임상 시험의 높은 비용, 숙련된 전문가 부족, 데이터 보안 및 지적재산권 보호와 관련된 문제 등의 요인으로 인해 시장 성장이 제한될 수 있습니다. 이러한 문제점에도 불구하고 전임상 CRO 시장에는 큰 성장 기회가 존재합니다. 그 원동력은 3D 세포배양, 장기 칩, 인실리콘 모델링과 같은 첨단 기술의 채택 확대이며, 이는 전임상 시험의 예측 정확도와 효율성 향상에 기여하고 있습니다. 또한 맞춤형 의료에 대한 수요 증가와 희귀질환 및 희귀의약품에 대한 관심이 높아짐에 따라 향후 수년간 전임상 CRO에 새로운 기회가 창출될 것으로 예상됩니다.
본 조사의 주요 특징:
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 저해요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 비임상 CRO 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계의 전임상 CRO 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 전임상 CRO 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 전임상 CRO 시장 : 서비스별, 2021-2033년
제5장 세계의 전임상 CRO 시장 : 유형별, 2021-2033년
제6장 세계의 전임상 CRO 시장 : 동물 모델별, 2021-2033년
제7장 세계의 전임상 CRO 시장 : 모델 시스템별, 2021-2033년
제8장 세계의 전임상 CRO 시장 : 용도별, 2021-2033년
제9장 세계의 전임상 CRO 시장 : 최종사용자별, 2021-2033년
제10장 세계의 전임상 CRO 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
KSA 26.06.10Preclinical CRO Market is estimated to be valued at USD 7.40 Bn in 2026 and is expected to reach USD 13.49 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.00% | 2033 Value Projection: | USD 13.49 Bn |
The global preclinical CRO market has witnessed significant growth in recent years, driven by the increasing demand for outsourcing preclinical research activities by pharmaceutical and biotechnology companies. Preclinical Contract Research Organizations (CROs) play a crucial role in the drug discovery and development process, providing a wide range of services such as toxicology testing, pharmacokinetic and pharmacodynamic studies, and animal model development. These organizations help streamline the preclinical phase of drug development, enabling pharmaceutical companies to focus on their core competencies and accelerate the delivery of new therapies to the market. The preclinical CRO market is highly competitive, with several key players operating globally, offering specialized services and advanced technologies to meet the evolving needs of their clients. As the pharmaceutical industry continues to face challenges such as rising research and development costs and increasing regulatory scrutiny, the demand for preclinical CRO services is expected to grow further in the coming years.
Market Dynamics:
The global preclinical CRO market is driven by several factors, including the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, the growing demand for specialized preclinical services, and the need to reduce drug development costs and timelines. Outsourcing preclinical studies to CROs allows companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, without the need for significant capital investments. Additionally, the increasing complexity of drug development, coupled with the need to comply with stringent regulatory requirements, has further fueled the demand for preclinical CRO services. However, the market growth may be restrained by factors such as the high cost of preclinical studies, the limited availability of skilled professionals, and the challenges associated with data security and intellectual property protection. Despite these challenges, the preclinical CRO market presents significant opportunities for growth, driven by the increasing adoption of advanced technologies such as 3D cell culture, organ-on-a-chip, and in silico modeling, which can help improve the predictivity and efficiency of preclinical studies. Moreover, the growing demand for personalized medicine and the increasing focus on rare diseases and orphan drugs are expected to create new opportunities for preclinical CROs in the coming years.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global preclinical CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Charles River Laboratories, Covance (Labcorp), WuXi AppTec, ICON plc, PPD (Part of Thermo Fisher Scientific), Medpace, Evotec SE, Syneos Health, BioReliance (Merck KGaA), Charles River, KCR, Parexel International, Inotiv, Toxikon, and Harlan Laboratories
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global preclinical CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical CRO market
Market Segmentation
- Service Insights (Revenue, USD Bn, 2021 - 2033)
- Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- GLP
- Non-GLP
- Compound Management
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Others
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Patient-Derived Organoid (PDO) Models
- Patient-Derived Xenograft (PDX) Models
- Animal Model Insights (Revenue, USD Bn, 2021 - 2033)
- Small Animal Model
- Large Animal Model
- Model System Insights (Revenue, USD Bn, 2021 - 2033)
- In Vivo
- In Vitro
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Metabolic Disorders
- Others
- End Users Insights (Revenue, USD Bn, 2021 - 2033)
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Research Institutes and Universities
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories
- Covance (Labcorp)
- WuXi AppTec
- ICON plc
- PPD (Part of Thermo Fisher Scientific)
- Medpace
- Evotec SE
- Syneos Health
- BioReliance (Merck KGaA)
- Charles River
- KCR
- Parexel International
- Inotiv
- Toxikon
- Harlan Laboratories
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Preclinical CRO Market, By Service
- Global Preclinical CRO Market, By Type
- Global Preclinical CRO Market, By Animal Model
- Global Preclinical CRO Market, By Model System
- Global Preclinical CRO Market, By Application
- Global Preclinical CRO Market, By End Users
- Global Preclinical CRO Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Preclinical CRO Market, By Service, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bioanalysis and DMPK studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- GLP
- Non-GLP
- Compound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Preclinical CRO Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Patient-Derived Organoid (PDO) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Patient-Derived Xenograft (PDX) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Preclinical CRO Market, By Animal Model, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Large Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Preclinical CRO Market, By Model System, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- In Vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- In Vitro
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Preclinical CRO Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Preclinical CRO Market, By End Users, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research Institutes and Universities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Preclinical CRO Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Covance (Labcorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PPD (Part of Thermo Fisher Scientific)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioReliance (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Toxikon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Harlan Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
